Evidence & Research Behind Myopia Management

Studies have shown that several treatments can slow the progression of childhood myopia. Here are a few peer-reviewed articles that support the strategies we offer.

Research from the ATOM2 study showed that low-dose atropine eye drops can safely slow the progression of childhood myopia. Children using 0.01% atropine had less prescription change and less eye growth over several years, with very few side effects.

This makes atropine a good option for parents looking for a gentle, proven treatment.

Research from a 2023 systematic review showed that Ortho-K lenses significantly slow axial eye growth in children, which helps reduce how quickly myopia progresses. The study confirmed that Ortho-K is an effective option for managing childhood myopia while also offering clear daytime vision.

The BLINK Study found that special multifocal soft contact lenses can help slow down how quickly a child’s nearsightedness worsens. Kids wearing these lenses had less prescription change than those wearing regular contacts.

The High Lens Add (HAL) Study looked at specially designed myopia-control glasses that use a “high add” treatment zone. Children who wore these lenses had slower prescription changes compared to children wearing regular glasses.